Close Menu

NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm Biocartis Group today reported a 9 percent decline in full-year 2016 revenues, as a drop in collaboration revenue offset strong demand for its real-time PCR-based Idylla platform and test cartridges.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.